TOP CONTRIBUTORS

Greg Aurand

www.zacks.com

WMGI AT A GLANCE

P/E ► 95.9 HIGH EV/EBITDA ► 13.2 AVG ROA ► 2.5% AVG ROE ► 1.7% AVG Debt to Equity ► 0.624 AVG Current Ratio ► 7.23 HIGH Interest Coverage Ratio ► 3.45 AVG

 

 

 

 

 

 

Wright Medical Group, Inc. (WMGI) is a global orthopedic device company specializing in the design, manufacture, and marketing of reconstructive joint devices and bio-orthopedic materials. Reconstructive joint devices are used to replace knee, hip, and other joints that have deteriorated through disease or injury. Bio-orthopedic materials are used to replace damaged or diseased bones, and to stimulate natural bone growth. Wright Medical primarily operates through three divisions: Orthopedic Implants, Orthobiologic Products, and Other Products. Through these divisions, the company offers large joint implants for the hip and knee extremity implants for the hand, elbow, shoulder, foot, and ankle and both synthetic and tissue-based bone graft substitute materials. The company derives revenue entirely from product sales. In 2006, Orthopedic Implants (hips, knees, extremities) generated 77% of revenue, Orthobiologic Products generated 19%, and Other Products generated 4%. The company distributes its products in over 60 countries around the world, through a combination of direct sales personnel and a network of independent distributors. In 2006, domestic sales were 62% of total revenues, and international contributed the remaining 38%. The company's website is www.wmt.com.

References